| Soft-Sided Vaccine Carrier | Short-distance transport by health workers, outreach teams, and mobile vaccination units. | Usually about 0.5–5 L of usable payload space, depending on design. | +2°C to +8°C for temperature-sensitive vaccines. | WHO PQS vaccine-carrier evaluations commonly use a minimum cold-life benchmark of approximately 15 hours under specified test conditions. | Testing can include cold-life performance, warm-condition exposure, coolant-pack configuration, internal temperature mapping, leakage, durability, and protection against freezing. | Reusable when cleaned, inspected, and maintained correctly. |
| Rigid Vaccine Carrier | Routine transport where greater structural protection and easier stacking are required. | Commonly about 1–6 L of usable payload space, varying by model. | +2°C to +8°C, with a design intended to prevent direct contact between vaccines and frozen coolant. | Approximately 15 hours is a commonly applied minimum benchmark for vaccine-carrier testing; some designs provide longer hold times. | Assessment may cover thermal performance, shock and drop resistance, lid security, coolant-pack placement, cleaning access, and payload protection. | Reusable; the shell and insulation should be checked for cracks, deformation, and loss of insulation. |
| Insulated Cold Box | Longer-distance transport, facility replenishment, and temporary storage during power interruptions. | Often about 5–25 L or more of usable payload space, depending on the class and configuration. | +2°C to +8°C for vaccines requiring refrigerated storage. | WHO PQS cold-box evaluations commonly use a minimum cold-life benchmark of approximately 48 hours under specified test conditions. | Testing generally considers cold life, ambient-temperature exposure, usable capacity, coolant conditioning, thermal uniformity, durability, and freeze protection. | Reusable for repeated distribution cycles with routine cleaning and maintenance. |
| Insulated Shipping Container | Domestic or international shipment of vaccines and other temperature-sensitive healthcare products. | From several litres to more than 100 L, depending on the shipping configuration. | Usually validated for +2°C to +8°C; other ranges may be used for products with different label requirements. | Typically validated for 24–120 hours or longer, based on route duration, ambient profile, payload, and coolant arrangement. | Validation should include thermal mapping, route simulation, worst-case ambient conditions, transport duration, payload configuration, and data-logger evidence. | May be reusable or single-use; the manufacturer’s validated life cycle must be followed. |
| Phase-Change Material Vaccine Bag | Compact last-mile transport using phase-change coolant packs designed for refrigerated products. | Commonly about 1–8 L of payload space, depending on the bag and insert system. | Designed to maintain the validated product range, commonly +2°C to +8°C. | Often approximately 12–30 hours, but the actual value must be established by product-specific testing. | The test must verify correct phase-change temperature, pack conditioning, thermal uniformity, payload arrangement, and protection from freezing. | Normally reusable; coolant packs require correct reconditioning before each cycle. |
| Passive Single-Use Shipping Bag | One-way delivery where return logistics, cleaning, or pack reconditioning is impractical. | Usually about 1–20 L, depending on the packaging format. | Must be validated for the vaccine’s labeled storage range, commonly +2°C to +8°C. | Usually 24–96 hours, subject to route-specific qualification and ambient conditions. | A transport qualification should document thermal performance, maximum duration, seasonal conditions, payload, coolant arrangement, and handling limits. It is not automatically a WHO PQS vaccine carrier. | Generally single-use unless specifically validated for reuse. |